We collected peripheral blood samples from RCC patients and their matched healthy controls, and detected the number of IL‐2 and IFN‐γ producing cells by implementing an enzyme‐linked immunospot (ELISPOT) assay. This evidence concerns the gene IL2 and renal cell carcinoma.